Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nuffield Department of Clinical Neuroscience’s Associate Professor Andrea Nemeth is leading the Oxford part of a gene therapy trial for Hungtinton’s disease.

Gene therapy trial for Huntington’s disease under way in Oxford © Oxford University Hospitals NHS Foundation Trust

This international collaborative trial, sponsored by Roche pharmaceuticals, is the first gene therapy trial for a neurodegenerative disease of the central nervous system. If successful, the trial could have implications not just for Huntington’s disease but also genetically similar conditions such as the spinocerebellar ataxias.

Read more (Nuffield Department of Clinical Neuroscience website)